Keep informed about the latest topics in global health.
#VaccinesWork
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
African Vaccine Manufacturing Accelerator (AVMA)
COVID-19
The Global Vaccine Impact Conference explained
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
FEATURED STORY
Everything you need to know about Gavi's incoming CEO, Dr Sania Nishtar
VACCINE PROFILES
Read series
KEY PUBLICATION
The 2023 Mid-Term Review Report
PROGRESS REPORT
24 October 2013
GAVI Alliance a top performer in leading transparency index
22 October 2013
GAVI supports Cambodia’s campaign to vaccinate children against measles and rubella
9 October 2013
GAVI welcomes Canada's support for measles vaccines
Vaccine to protect South Asian children against devastating disease set for GAVI support
8 October 2013
GAVI statement on latest trial data on malaria vaccine candidate RTS,S
8 August 2013
GAVI responds to Medecins Sans Frontieres
28 July 2013
Price reduced for vaccine against pneumococcal disease
25 July 2013
Research shows high impact of Hib vaccines in developing countries
18 July 2013
UK Government recognises GAVI's progress
12 June 2013
GAVI Board asks to begin preparations for introduction of inactivated polio vaccine and considers investment in other new vaccines
30 May 2013
GAVI Alliance welcomes priority given to health and immunisation in High Level Panel Report
14 May 2013
Rotavirus leading cause of diarrhoea